Immune checkpoint inhibitor-induced vitiligo in advanced melanoma could be related to increased levels of CCL19

T. Fujimura; K. Tanita; Y. Sato; C. Lyu; Y. Kambayashi; Y. Fujisawa; H. Uchi; Y. Yamamoto; A. Otsuka; K. Yoshino; S. Matsushita; T. Funakoshi; S. Fukushima; H. Hata; A. Hashimoto; S. Aiba

doi:10.1111/bjd.18721

Immune checkpoint inhibitor-induced vitiligo in advanced melanoma could be related to increased levels of CCL19

T. Fujimura, K. Tanita, Y. Sato, C. Lyu, Y. Kambayashi, Y. Fujisawa, H. Uchi, Y. Yamamoto, A. Otsuka, K. Yoshino, S. Matsushita, T. Funakoshi, S. Fukushima, H. Hata, A. Hashimoto, S. Aiba

Research output: Contribution to journal › Letter › peer-review

9 Citations (Scopus)

Original language	English
Pages (from-to)	1297-1300
Number of pages	4
Journal	British Journal of Dermatology
Volume	182
Issue number	5
DOIs	https://doi.org/10.1111/bjd.18721
Publication status	Published - 2020 May 1

Access to Document

10.1111/bjd.18721

Cite this

Fujimura, T., Tanita, K., Sato, Y., Lyu, C., Kambayashi, Y., Fujisawa, Y., Uchi, H., Yamamoto, Y., Otsuka, A., Yoshino, K., Matsushita, S., Funakoshi, T., Fukushima, S., Hata, H., Hashimoto, A., & Aiba, S. (2020). Immune checkpoint inhibitor-induced vitiligo in advanced melanoma could be related to increased levels of CCL19. British Journal of Dermatology, 182(5), 1297-1300. https://doi.org/10.1111/bjd.18721

@article{e35868a8b23c4861bfca2c23784291e9,

title = "Immune checkpoint inhibitor-induced vitiligo in advanced melanoma could be related to increased levels of CCL19",

author = "T. Fujimura and K. Tanita and Y. Sato and C. Lyu and Y. Kambayashi and Y. Fujisawa and H. Uchi and Y. Yamamoto and A. Otsuka and K. Yoshino and S. Matsushita and T. Funakoshi and S. Fukushima and H. Hata and A. Hashimoto and S. Aiba",

year = "2020",

month = may,

day = "1",

doi = "10.1111/bjd.18721",

language = "English",

volume = "182",

pages = "1297--1300",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Oxford University Press",

number = "5",

}

Fujimura, T, Tanita, K, Sato, Y, Lyu, C, Kambayashi, Y, Fujisawa, Y, Uchi, H, Yamamoto, Y, Otsuka, A, Yoshino, K, Matsushita, S, Funakoshi, T, Fukushima, S, Hata, H, Hashimoto, A & Aiba, S 2020, 'Immune checkpoint inhibitor-induced vitiligo in advanced melanoma could be related to increased levels of CCL19', British Journal of Dermatology, vol. 182, no. 5, pp. 1297-1300. https://doi.org/10.1111/bjd.18721

TY - JOUR

T1 - Immune checkpoint inhibitor-induced vitiligo in advanced melanoma could be related to increased levels of CCL19

AU - Fujimura, T.

AU - Tanita, K.

AU - Sato, Y.

AU - Lyu, C.

AU - Kambayashi, Y.

AU - Fujisawa, Y.

AU - Uchi, H.

AU - Yamamoto, Y.

AU - Otsuka, A.

AU - Yoshino, K.

AU - Matsushita, S.

AU - Funakoshi, T.

AU - Fukushima, S.

AU - Hata, H.

AU - Hashimoto, A.

AU - Aiba, S.

PY - 2020/5/1

Y1 - 2020/5/1

UR - http://www.scopus.com/inward/record.url?scp=85076746442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076746442&partnerID=8YFLogxK

U2 - 10.1111/bjd.18721

DO - 10.1111/bjd.18721

M3 - Letter

C2 - 31746456

AN - SCOPUS:85076746442

SN - 0007-0963

VL - 182

SP - 1297

EP - 1300

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 5

ER -

Immune checkpoint inhibitor-induced vitiligo in advanced melanoma could be related to increased levels of CCL19

Access to Document

Other files and links

Cite this